Why Sonoma Pharma (SNOA) Stock Skyrocketing On Thursday

Sonoma Pharmaceuticals Inc SNOA stock doubled in reaction to the launch of two new dental products.
OroGenix Oral Hygiene Rinse is Sonoma's second dental product in the U.S. and was developed with its partner Gabriel Science LLC.
Additionally, Sonoma and its partner, Medical Systems Solutions, have launched Microdacyn Oral Care for professional and consumer use in Switzerland.
After launching Endocyn for root canal irrigation in December 2020, Sonoma's second dental product in the U.S. is an oral hygiene rinse.
OroGenix Oral Hygiene Rinse uses Sonoma's patented Microcyn technology to cleanse teeth, gums, and mouth.
In Europe, Microdacyn60 Oral Care is intended to combat oral and pharyngeal infections and inflammation and reduce pain and coughing.
Price Action: SNOA shares are up 123.10% at $12.47 during the market session on the last check Thursday.